Why the study?
The study was conducted to pinpoint the risk variables accountable for the variability in congestive heart failure patients' survival times.
What are the risk factors for mortality in patients with congestive heart failure in Southern Ethiopia?
Cohort (n=199)
No
What are the risk factors for mortality in patients with congestive heart failure in Southern Ethiopia?
Hazard Ratio: 6.722 (95% CI 2.7978–16.1526)
p-value: p=2.04e-05
In a cohort of heart failure patients in Ethiopia, tuberculosis, diabetes, chronic kidney disease, smoking, and left ventricular ejection fraction were identified as significant predictors of mortality.
Chronic heart failure happens when the heart’s muscle is incapable of circulate sufficient blood to satisfy the requirements of the body for both oxygen and blood. In other sense, the heart is overwhelmed by its load. The goal of this study is to pinpoint the risk variables accountable for the variability in congestive heart failure patients’ survival times from January 2017 to December 2021 at ArbaMinch General Hospital in South Ethiopia. Utilizing cox proportional hazard models, the data was examined. A retrospective investigation was conducted. Data was gathered from the cards of 199 congestive heart failure patients who were being followed up on using a straightforward random sampling approach. We discovered that 21.6 percent of the 199 patients with congestive heart failure investigated died, while the remaining 78.4% were censoring. Patients’ mean baseline left ventricular ejection fraction was 43.18 percent (with a standard deviation of 13.928 percent), implying that each pulse expels 43.18 percent of the blood in the left ventricle. Patients with heart failure who tested positive for tuberculosis had a substantially increased chance of death. Left ventricular ejection fraction, tuberculosis, diabetes militias, etiology of heart failure, type of congestive heart failure, smoking status, and chorionic kidney disease were originate to be significant risk factors for death in patients with congestive heart failure. As a result, physicians are encouraged to pay greater attention to heart failure patients.
No takes yet. Share an insight, caveat, or question.
Kumaso et al. (2023) conducted a cohort in Congestive heart failure (n=199). Tuberculosis vs. Tuberculosis negative was evaluated on Time to death (HR 6.722, 95% CI 2.7978-16.1526, p=2.04e-05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: